Endocrine-disrupting chemicals (EDCs) can contribute to the development of certain disorders and are known to have a high health-care burden in some countries. A new analysis has revealed the substantial impact of EDCs on health and associated costs in the USA.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Attina, T. M. et al. Exposure to endocrine-disrupting chemicals in the USA: a population-based disease burden and cost analysis. Lancet Diabetes Endocrinol. http://dx.doi.org/10.1016/S2213-8587(16)30275-3 (2016).
Trasande, L. et al. Estimating burden and disease costs of exposure to endocrine disrupting chemicals in the European Union. J. Clin. Endocrinol. Metab. 100, 1245–1255 (2015).
Skakkebaek, N. E. et al. Male reproductive disorders and fertility trends: influences of environment and genetic susceptibility. Physiol. Rev. 96, 55–97 (2016).
Bergman, A., Heindel, J. J., Jobling, S., Kidd, K. A. & Zoeller, R. T. (eds) State of the Science of Endocrine Disrupting Chemicals — 2012 (WHO–UNEP, 2013).
Slama, R. et al. Scientific issues relevant to setting regulatory criteria to identify endocrine-disrupting substances in the European Union. Environ. Health Perspect. 124, 1497–1503 (2016).
Jones, G., Garthwaite, D., Wynne, S. & Twining, G. Agronomic and economic impact assessment for possible human health and ecotoxicology criteria for endocrine disrupting chemicals. Report to Chemicals Regulation Directorate. FERA randd.defra.gov.uk/Document.aspx?Document=11346_PS2818finalreportfull.pdf (2013).
Kristensen, D. et al. Analgesics use — prevalence, biomonitoring and endocrine and reproductive effects. Nat. Rev. Endocrinol. 12, 381–393 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Kortenkamp, A. The burden of endocrine-disrupting chemicals in the USA. Nat Rev Endocrinol 13, 6–7 (2017). https://doi.org/10.1038/nrendo.2016.198
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2016.198
This article is cited by
-
Maternal bisphenol A and triclosan exposure and allergic diseases in childhood: a meta-analysis of cohort studies
Environmental Science and Pollution Research (2022)
-
The occurrence and risk assessment of phenolic endocrine-disrupting chemicals in Egypt’s drinking and source water
Environmental Science and Pollution Research (2020)